PNC FINANCIAL SERVICES GROUP, INC. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 123 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,242
-16.6%
1440.0%0.00%
Q2 2023$1,490
-4.6%
1440.0%0.00%
Q1 2023$1,562
-3.3%
1440.0%0.00%
Q4 2022$1,616
-19.2%
1440.0%0.00%
Q3 2022$2,0000.0%1440.0%0.00%
Q2 2022$2,0000.0%1440.0%0.00%
Q1 2022$2,000144
+63.6%
0.00%
Q4 2021$0880.0%0.00%
Q3 2021$0
-100.0%
880.0%0.00%
Q2 2021$2,0000.0%880.0%0.00%
Q1 2021$2,00088
+57.1%
0.00%
Q4 2020$0560.0%0.00%
Q3 2020$0
-100.0%
560.0%0.00%
Q2 2020$2,0000.0%560.0%0.00%
Q1 2020$2,0000.0%560.0%0.00%
Q4 2019$2,0000.0%560.0%0.00%
Q3 2019$2,000560.0%0.00%
Q2 2019$0
-100.0%
560.0%0.00%
Q1 2019$2,0000.0%560.0%0.00%
Q4 2018$2,0000.0%560.0%0.00%
Q3 2018$2,000
-50.0%
56
-64.1%
0.00%
Q2 2018$4,000
+100.0%
156
+178.6%
0.00%
Q1 2018$2,0000.0%56
+55.6%
0.00%
Q4 2017$2,000
-99.0%
36
-99.4%
0.00%
Q3 2016$210,000
+54.4%
5,800
-3.2%
0.00%
Q2 2016$136,000
+23.6%
5,992
+3.3%
0.00%
Q1 2016$110,000
+14.6%
5,8000.0%0.00%
Q4 2015$96,000
+50.0%
5,8000.0%0.00%
Q3 2015$64,000
-15.8%
5,8000.0%0.00%
Q2 2015$76,000
-24.0%
5,800
-0.3%
0.00%
Q1 2015$100,000
+16.3%
5,815
+0.3%
0.00%
Q4 2014$86,000
-68.1%
5,800
-50.4%
0.00%
Q3 2014$270,000
+2600.0%
11,684
+4014.1%
0.00%
Q2 2014$10,0002840.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$78,677,17613.94%
Irenic Capital Management LP 1,700,937$19,084,5139.15%
Weiss Asset Management LP 7,457,060$83,668,2133.41%
Newtyn Management, LLC 1,450,000$16,269,0003.36%
Palliser Capital (UK) Ltd 97,100$1,089,4622.65%
Chescapmanager LLC 850,988$9,5482.24%
Park West Asset Management LLC 1,920,324$21,546,0352.11%
Baupost Group 11,419,226$128,1242.09%
Saturn V Capital Management LP 141,339$1,334,3421.11%
Oasis Management Co Ltd. 296,960$3,331,8910.66%
View complete list of THERAVANCE BIOPHARMA INC shareholders